Elecsys N-MID Osteocalcin
Classification
- Category
- Immunoassay & Serology
- Technology
- Chemiluminescence Immunoassay
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
Intended useImmunoassay for the in vitro quantitative determination of N‑MID osteocalcin in human serum and plasma. The determination is used for the control of antiresorptives therapeutic efficiency, e.g. for patients with osteoporosis or hypercalcemia.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers.
for patients with osteoporosis or hypercalcemia.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers.
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-06
2026-10-28
availability varies